Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of alzheimer's disease

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Jung, Bong Kwang ^a   Pyo, Kyoung Ho ^a   Shin, Ki Young ^a   Hwang, Young Sang ^a   Lim, Hyoungsub ^b   Lee, Sung Joong ^b   Moon, Jung Ho ^a   Lee, Sang Hyung ^a,c   Suh, Yoo Hun ^a   Chai, Jong Yil ^a   Shin, Eun Hee ^a,d  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; AMYLOID;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HIPPOCAMPUS; IMMUNOSUPPRESSIVE TREATMENT; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; MICROGLIA; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; ANIMAL BEHAVIOR; BRAIN; CELL CULTURE; CYTOLOGY; DISEASE MODEL; ISOLATION AND PURIFICATION; LEARNING; METABOLISM; NERVE DEGENERATION; PATHOLOGY; TOXOPLASMA; VIROLOGY;

MURINAE; MUS; TOXOPLASMA GONDII;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; INTERFERON-GAMMA; INTERLEUKIN-10; LEARNING; MEMORY DISORDERS; MICE; MICROGLIA; NERVE DEGENERATION; NITRIC OXIDE; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TRANSFORMING GROWTH FACTOR BETA;

EID: 84863358152     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033312     Document Type: Article

References (46)

1. Tenter AM, Heckeroth AR, Weiss LM, (2000) Toxoplasma gondii: from animals to humans. Int J Parasitol 30: 1217-1258.
2. Bhopale GM, (2003) Pathogenesis of toxoplasmosis. Comp Immunol Microbiol Infect Dis 26: 213-222.
3. Mordue DG, Monroy F, Regina ML, Dinarello CA, Sibley LD, (2001) Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol 167: 4574-4584.
4. Hayashi S, Chan CC, Gazzinelli R, Roberge FG, (1996) Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. J Immunol 156: 1476-1481.
5. Rosenfeld C, Martinez R, Seabra S, Sant'Anna C, Gonçalves JGR, et al. (2005) Toxoplasma gondii prevents neuron degeneration by interferon-γ-activated microglia in a mechanism involving inhibition of inducible nitric oxide synthase and transforming growth factor-β1 production by infected microglia. Am J Pathol 167: 1021-1031.
6. Alexander J, Scharton-Kersten TM, Yap G, Roberts CW, Liew FY, et al. (1997) Mechanisms of innate resistance to Toxoplasma gondii infection. Phil Trans R Soc Lond B 352: 1355-1359.
7. Rosenfeld C, Martinez R, Figueiredo RT, Bozza MT, Lima FRS, et al. (2003) Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect Immun 71: 2047-2057.
8. Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, et al. (2004) Role of microglia in central nervous system infections. Clin Microbiol Rev 17: 942-964.
9. Lee YJ, Han SB, Nam SY, Oh KW, Hong JT, (2010) Inflammation and Alzheimer's disease. Arch Pharm Res 33: 1539-1556.
10. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
11. Akiyama H, McGeer PL, (1990) Brain microglia constitutively express β-2 integrins. J Neuroimmunol 30: 81-93.
12. Brown GC, Bal-Price A, (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27: 325-355.
13. Fernández-Vizarra P, Fernández AP, Castro-Blanco S, Encinas JM, Serrano EJ, et al. (2004) Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol Dis 15: 287-305.
14. Heneka MT, O'Banion MK, (2007) Inflammatory processes in Alzheimer's disease. J Neuroimmunol 184: 69-91.
15. Heneka MT, O'Banion MK, Terwel D, Kummer MP, (2010) Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 117: 919-947.
16. Kusbeci OY, Miman O, Yaman M, Aktepe OC, Yazar S, (2011) Could Toxoplasma gondii have any role in Alzheimer disease? Alzheimer Dis Assoc Disord 25: 1-3.
17. Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, et al. (2010) Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Psychiatry Research 177: 263-265.
18. Miman O, Kusbeci OY, Aktepe OC, Cetinkaya Z, (2010) The probable relation between Toxoplasma gondii and Parkinson's disease. Neuroscience letters 475: 129-131.
19. Taylor S, (2011) Does Toxoplasma gondii play a role in obsessive-compulsive disorder? Psychiatry Research 178 in press.
20. Neumann H, Kotter MR, Franklin RJM, (2009) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132: 288-295.
21. Sastre M, Dewachter I, Landreth GE, Willson TM, Klockgether T, et al. (2003) Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase. J Neurosci 23: 9796-9804.
22. Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, et al. (2002) The relationship between Aβ and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22: 1858-1867.
23. Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, et al. (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41: 27-33.
24. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, et al. (2001) Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 154: 357-365.
25. Pappas G, Roussos N, Falagas ME, (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39: 1385-1394.
26. Wagner A, Förster-Waldl E, Garner-Spitzer E, Schabussova I, Kundi M, et al. (2009) Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice. Int J Parasitol 39: 465-472.
27. Fischer HG, Nitzgen B, Reichmann G, Groβ U, Hadding U, (1997) Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol Res 83: 637-641.
28. Khan IA, Matsuura T, Kasper LH, (1995) IL-10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice. Parasite Immunol 17: 185-195.
29. Deckert-Schlüter M, Buck C, Weiner D, Kaefer N, Rang A, et al. (1997) Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis. J Neuroimmunol 76: 167-176.
30. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA, (2005) A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 165: 63-74.
31. Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, et al. (2008) Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation 5: 37 doi:10.1186/1742-2094-5-37.
32. Huang WC, Yen FC, Shie FS, Pan CM, Shiao YJ, et al. (2010) TGF-β1 blockade of microglial chemotaxis toward Aβ aggregates involves SMAD signaling and down-regulation of CCL5. J Neuroinflammation 7: 28 doi:10.1186/1742-2094-7-28.
33. Wille U, Villegas EN, Striepen B, Roos DS, Hunter CA, (2001) Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii. Parasite Immunol 23: 291-296.
34. Guo JT, Yu J, Grass D, de Beer FC, Kindy MS, (2002) Inflammation-dependent cerebral deposition of serum amyloid A protein in a mouse model of amyloidosis. J Neurosci 22: 5900-5909.
35. Wyss-Coray T, Lin C, Yan F, Yu GQ, Rohde M, et al. (2001) TGF-ß1 promotes microglial amyloid-ß clearance and reduces plaque burden in transgenic mice. Nat Med 7: 612-618.
36. Tesseur I, Zou K, Esposito L, Bard F, Berber E, et al. (2006) Deficiency in neuronal TGF-β signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest 116: 3060-3069.
37. Schlüter D, Kaefer N, Hof H, Wiestler OD, Deckert-Schlüter M, (1997) Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am J Pathol 150: 1021-1035.
38. Gulinello M, Acquarone M, Kim JH, Spray DC, Barbosa HS, et al. (2010) Acquired infection with Toxoplasma gondii in adult mice results in sensorimotor deficits but normal cognitive behavior despite widespread brain pathology. Microb Infect 12: 528-537.
39. Howe DK, Sibley LD, (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172: 1561-1566.
40. Howe DK, Honoré S, Derouin F, Sibley LD, (1997) Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 35: 1411-1414.
41. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, et al. (1996) Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.
42. Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, et al. (2001) Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci 21: 372-381.
43. Ha TY, Chang KA, Kim JA, Kim HS, Kim S, et al. (2010) S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576, AD animal model. PLoS One 5: e8840.
44. Pyo KH, Jung BK, Chai JY, Shin EH, (2010) Suppressed CD31 expression in sarcoma-180 tumors after injection with Toxoplasma gondii lysate antigen in BALB/c mice. Korean J Parasitol 48: 171-174.
45. Hickman SE, Allison EK, El Khoury J, (2008) Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 28: 8354-8360.
46. Cho IH, Hong J, Suh EC, Kim JH, Lee H, et al. (2008) Role of microglial IKKβ in kainic acid-induced hippocampal neuronal cell death. Brain 131: 3019-3033.